Page 124 - GTM-4-3
P. 124

Global Translational Medicine                                      Rapid diagnostic imaging on biopsy needle



            Eliminating the need for a clean glass surface would   Acknowledgments
            streamline the imaging process. Integrating FIBI thick
            tissue imaging, which can produce a 30× greater signal-  We extend our gratitude to Dr. Farzad Fereidouni at the
            to-noise ratio compared to MUSE images, can accelerate   University of California, Davis, for his pioneering work
            the imaging process and eliminate UV optical hazards, as   in MUSE imaging  and his invaluable contributions to
            well as the need for expensive quartz glass. Although the   the development of the CoreView ION system. Dr. Jane
            extended depth of focus algorithm would eliminate the   Brock provided the photograph taken of the CNB
            need for tissue compression, its deployment requires fast   procedure using a reusable biopsy gun. We appreciate
            axial scanning, which would increase cost and complexity   the input of Dr.  Beatrice Wiafe Addai for insightful
            for the future portable CoreView ION system. While these   discussions on the global needs for rapid BC diagnosis at
            technological adaptations are promising for low-resource   the bedside and the unmet need for a low-cost portable
            and point-of-care applications, clinical translation   CoreView system for more rural healthcare clinics in
            will  ultimately require validation  using human  biopsy   West Africa.
            specimens to confirm clinical diagnostic accuracy and   Funding
            performance. Expanding accessibility and accelerating
            diagnosis with AI-enhanced analysis of thick tissue biopsy   This research was made possible through financial support
            images are within reach, as these pre-clinical results suggest   from the National Cancer Institute of the National Institutes
            that the CoreView instrument can provide rapid, point-of-  of Health under grants R21CA246359 and R33CA278544,
            care diagnosis for the most prevalent cancers in Africa: BC,   awarded through the Innovative Molecular Analysis
            cervical cancer, and prostate cancer. 28-32        Technologies program, as well as grant U01CA269191.
                                                               The MUSE microscope and camera were purchased from
            4. Conclusion                                      early-phase translational grants (S2019_SEIBEL_7268)

            The CoreView ION system demonstrates the feasibility   from UW Commotion and the Washington Research
            of  rapid,  on-needle  imaging  for  CNB  analysis,  offering   Foundation, Seattle, Washington.
            a potential low-cost point-of-care solution for BC   Conflict of interest
            diagnostics. By integrating MUSE imaging with a more
            streamlined workflow, this system enables bedside   Matthew D. Carson and Eric J. Seibel are co-authors of a
            visualization of biopsy samples, compared to the days   patent owned by the UW. They are also the participants in
            to  months  of  delays  experienced  now  in  low-resource   the royalty-sharing program.
            settings. Further optimization and clinical validation with
            human tissue will be necessary to fully establish its role in   Author contributions
            improving BC survival rates by providing greater access to   Conceptualization: Eric J. Seibel, Matthew D. Carson
            these new rapid diagnostic pathways. This approach is a   Investigation: Jocelyn R. Jensen, Duy Do, Yuan-ping Chang,
            significant advancement in pathology, using thick tissue   Suzanne Dintzis, Richard M. Levenson
            biopsy imaging (MUSE and FIBI), as on-needle imaging   Methodology: All authors
            has not been previously explored. By enabling real-time   Writing–original draft: Jocelyn R. Jensen
            evaluation at the point of care, the CoreView ION system   Writing–review & editing: Eric J. Seibel, Matthew D.
            has the potential to greatly reduce patient burden, expedite   Carson, Suzanne Dintzis, Richard M. Levenson
            treatment decisions, and ultimately improve clinical
            outcomes in BC diagnostics.                        Ethics approval and consent to participate

            Supplemental information                           De-identified human prostate tissue images were provided
                                                               by the University of California, Davis, under Institutional
            Video S1. Video demonstration of the CoreView imaging   Review Board exemption FWA No: 00004557, granted
            on needle concept. The objective lens is focused on the top   on June 23, 2023. The exemption was issued under the
            surface of the compressed tissue that rests on the coring   supervision of Principal Investigator Dr. Richard Levenson.
            needle. Only the contacting parts (mechanical extension   As all samples were de-identified before transfer, informed
            of the objective lens and the small specimen chamber) are   consent was not required in accordance with institutional
            shown in cross-section.                            and federal guidelines.
            Video S2. Video demonstration of CoreView imaging on   Consent for publication
            needle workflow with animated computer-aided design
            drawings.                                          Not applicable.



            Volume 4 Issue 3 (2025)                        116                          doi: 10.36922/GTM025170039
   119   120   121   122   123   124   125   126   127   128   129